Clinical Trial

Evaluation of the Effectiveness of Capacitive and Resistive Energy Transfer Therapy for Lateral Epicondylitis

Recruiting
View on ClinicalTrials.gov →
Summary
This prospective, randomized, double-blind, sham-controlled clinical trial aims to evaluate the efficacy of Capacitive and Resistive Energy Transfer (TECAR) therapy in patients with lateral epicondylitis. Participants will be randomly assigned to either a TECAR plus exercise group or a sham TECAR plus exercise group. Both groups will receive a standardized home exercise program including elbow and wrist range-of-motion, stretching, eccentric strengthening, and handgrip strengthening exercises. The TECAR group will additionally receive active TECAR therapy, while the control group will receive sham TECAR treatment using the same device and treatment protocol without therapeutic energy delivery. Outcome assessments will be performed by a blinded evaluator at baseline, immediately after treatment, and at 1- and 2-month follow-up visits. The study aims to determine whether TECAR therapy provides additional benefits in pain relief, functional improvement, and clinical outcomes when combined with exercise therapy in patients with lateral epicondylitis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-03.
Trial Details
NCT Number NCT07634224
Lead Sponsor Gaziantep City Hospital
Conditions Lateral Epicondylitis, Capacitive and Resistive Electric Transfer Therapy, Exercise
Enrollment 62 participants
Start Date 2026-05-11
Primary Completion 2026-12-11 (estimated)
Study Completion 2027-05-11 (estimated)
Updated on ClinicalTrials.gov 2026-06-11